| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ce8c8f0c7cab044e35235b55c3abda23 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-734
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2015-8518
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-727
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-922
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2510-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2330-51 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56966
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0641
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0644
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 |
| filingDate |
2017-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d46b61911cb1c9a0c1d53f409da08641
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_414119654b39a6630ef8d3c4f5a029e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e1124def375b28d55eaa15cef737157
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b9edb1aa3fd940f4d2b37bd04246c3b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dab1d8afadccd957980284d634b9bf67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2c3c6dedc17c3336b4e986ba614c0bd |
| publicationDate |
2019-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20190026819-A |
| titleOfInvention |
Compositions and methods related to therapeutic cell systems expressing exogenous RNA |
| abstract |
The present invention encompasses compositions and methods related to red blood cells comprising an exogenous RNA encoding a protein. The exogenous RNA may comprise a heterologous non-translated region comprising a regulatory element. Alternatively or in combination, the exogenous RNA may comprise a chemical modification. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023075122-A1 |
| priorityDate |
2016-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |